Chuck Royce's KURA Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 609,985 shares of Kura Oncology, Inc. (KURA) worth $6.69 M, representing 0.05% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in KURA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Kura Oncology (KURA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kura Oncology (KURA) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +609,985 | New Buy | 609,985 | $10.97 |
Chuck Royce's Kura Oncology Investment FAQs
Chuck Royce first purchased Kura Oncology, Inc. (KURA) in Q2 2026, acquiring 609,985 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Kura Oncology, Inc. (KURA) for 1 quarters since Q2 2026.
Chuck Royce's largest addition to Kura Oncology, Inc. (KURA) was in Q2 2026, adding 609,985 shares worth $6.69 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 609,985 shares of Kura Oncology, Inc. (KURA), valued at approximately $6.69 M.
As of the Q2 2026 filing, Kura Oncology, Inc. (KURA) represents approximately 0.05% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Kura Oncology, Inc. (KURA) was 609,985 shares, as reported at the end of Q2 2026.